An update on primary prevention of cardiovascular disease (CVD). In this article, we focus on risk factor management for people with established CVD, with the aim of preventing further cardiovascular events.
The British Heart Valve Society (BHVS) has produced a book for patients, all about heart valve disease. It is available for purchase through the BHVS website: https://www.bhvs.org.uk/book/
It was written with patients in mind and with heavy input from patients. Initial feedback has been really positive. It has been beautifully illustrated by a professional graphic designer.
As we are all aware, due to the COVID-19 pandemic, fewer people have sought help when experiencing symptoms of cardiovascular disease and stroke. Despite TV advertisements and government messaging, we are still seeing an increase in deaths due to heart disease and strokes.
Public Health England has just published the latest iteration of their CVD prevention packs which provide STP/CCG/Practice level data around all aspects of cardiovascular disease prevention.
According to the British Heart Foundation, many people with heart failure are not getting the care they need. This new report sets out a blueprint for how health and care services can better meet patient needs and help people live better for longer.
Cardiology, Renal and Metabolic (CaReMe) group have produced a very helpful leaflet for people with diabetes on SGLT-2 inhibitors.
This new report highlights some major issues surrounding the contemporary diagnosis of heart failure.
Use these top tips to assist your virtual consultation with adult patients who have been diagnosed with chronic heart failure with reduced ejection fraction.
This webinar is a collaboration between Thrombosis UK, Primary Care Cardiovascular Society (PCCS) and will consider: What is the pathway and action for primary care managing acute but not hospitalised thrombosis and patients late presenting with respiratory symptoms?
Use these top tips to get the most out of your virtual consultations with your adult patients who have been diagnosed with Chronic Heart Failure with reduced ejection fraction
Assessing fitness to drive: a guide for medical professionals
The purpose of this paper is to explain the background to dosing decisions for DOACs in patients with impaired renal function. The paper focuses on the use of DOACs in patients with atrial fibrillation and provides cases from clinical practice as examples. It is intended as a practice aid, not national guidance, and is particularly suitable for new or less experienced practitioners working in primary care.